Home » Newsletters » BioWorld Science

BioWorld Science

April 5, 2001

View Archived Issues

Renewed focus on oncology products at Transgene

AltaRex reports 2000 update

Clinical data reported for an optimized Theratope vaccine formulation

Pharmagenesis establishes development teams for two cancer treatment drug candidates

Cypress Bioscience and Georgetown collaborate on treatment for fibromyalgia syndrome

FDA supports Vical's Allovectin-7 clinical development program

Apomate begins phase II evaluation for cancer detection

Genelabs presents DNA-binding antifungal agents

Aventis creates new Gencell entity and restructures alliance with Introgen

Herceptin receives Japanese approval for treatment of metastatic breast cancer

Carboxypeptidase A-activated antifolate prodrug identified by Dana-Farber

DuPont identifies small-molecule TACE inhibitors for inflammation, autoimmune diseases

Orphan drug designation granted in Europe for Trisenox

Traditional Chinese medicinal formulation useful for alleviating toxicity of chemotherapy

FDA approves Celltech's once-daily ADHD treatment

New topoisomerase I-interactive fluoroindolocarbazole presented by BMS at AACR meeting

Antisense approaches to diabetes discussed at ACS by Isis

Launch announced for Viadur for advanced prostate cancer

Ark Therapeutics obtains positive results in EG-009 phase I/IIa trial

GSK discusses discovery and SAR for new series of dual PPARgamma/PPARalpha activators

Sch-62373, a dual NK1/NK2 antagonist from a series of 2-phenylpiperazines

New TAP anticancer therapeutic CPI-0004Na: design and synthesis reported this week

Sankyo presents new tachykinin antagonists and potential uses

Novel naturally produced compound is selective against H. pylori

Muscarinic M3-selective antagonists designed at Banyu

Thiophene NPY Y5 receptor ligands useful for eating and other disorders

Meiji Seika reports new series interacting with 5-HT4 receptors

Japanese patent covers preparation and use of beta3-adrenoceptor agonists

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...